Tackling obesity during the COVID-19 pandemic.
作者信息
Akirov Amit, Cahn Avivit, Del Prato Stefano, Home Philip, Van Gaal Luc, Chan Juliana, Ning Guang, Raz Itamar
机构信息
Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
Diabetes Metab Res Rev. 2021 Mar;37(3):e3393. doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.
Abstract
摘要
相似文献
1
Tackling obesity during the COVID-19 pandemic.在新冠疫情期间应对肥胖问题。
Diabetes Metab Res Rev. 2021 Mar;37(3):e3393. doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.
2
Diabetes, obesity and COVID-19: A complex interplay.糖尿病、肥胖与 COVID-19：复杂的相互作用。
Diabetes Obes Metab. 2020 Oct;22(10):1892-1896. doi: 10.1111/dom.14134. Epub 2020 Jul 28.
3
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.糖尿病患者发生重症 COVID-19 的入院前预测因子。
J Diabetes Complications. 2021 Aug;35(8):107967. doi: 10.1016/j.jdiacomp.2021.107967. Epub 2021 May 28.
4
COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults.COVID-19 自我隔离与成年人体重增加风险因素。
Curr Obes Rep. 2021 Sep;10(3):423-433. doi: 10.1007/s13679-021-00449-7. Epub 2021 Jul 12.
5
The Centrality of Obesity in the Course of Severe COVID-19.肥胖在重症 COVID-19 病程中的核心地位。
Front Endocrinol (Lausanne). 2021 Mar 11;12:620566. doi: 10.3389/fendo.2021.620566. eCollection 2021.
6
Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).肥胖症和糖尿病是导致 2019 年冠状病毒病（COVID-19）重症的高危因素。
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377. doi: 10.1002/dmrr.3377. Epub 2020 Jul 20.
7
Controlled obesity status: a rarely used concept, but with particular importance in the COVID-19 pandemic and beyond.控制肥胖状态：一个很少使用的概念，但在 COVID-19 大流行及以后具有特殊重要性。
J Endocrinol Invest. 2021 Apr;44(4):877-880. doi: 10.1007/s40618-020-01389-0. Epub 2020 Aug 29.
8
Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity.肥胖患者既往代谢和减重手术与 2019 年冠状病毒病（COVID-19）严重程度的关联。
Surg Obes Relat Dis. 2021 Jan;17(1):208-214. doi: 10.1016/j.soard.2020.10.026. Epub 2020 Nov 23.
9
Self-isolation.自我隔离
CJEM. 2021 Jan;23(1):128-129. doi: 10.1007/s43678-020-00028-0. Epub 2020 Dec 10.
10
COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.肥胖患者 COVID-19 严重程度：临床干预的潜在机制和分子靶点。
Obes Res Clin Pract. 2021 Mar-Apr;15(2):163-171. doi: 10.1016/j.orcp.2021.01.004. Epub 2021 Jan 19.
引用本文的文献
1
The Challenges and Strategies towards Healthy Eating during COVID-19 Home Confinement Period among Working Adults with BMI ≥ 25 kg/m Enrolled in a Weight Loss Program: Qualitative Findings.新冠肺炎居家隔离期间，体重指数（BMI）≥25kg/m2 的参加减肥计划的成年工作者健康饮食的挑战与策略：定性研究结果。
Int J Environ Res Public Health. 2022 May 30;19(11):6656. doi: 10.3390/ijerph19116656.
本文引用的文献
1
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素：一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
2
Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.内脏脂肪与 COVID-19 患者需要重症监护的关联性最强。
Metabolism. 2020 Oct;111:154319. doi: 10.1016/j.metabol.2020.154319. Epub 2020 Jul 23.
3
Changes in Body Weight, Physical Activity, and Lifestyle During the Semi-lockdown Period After the Outbreak of COVID-19 in China: An Online Survey.中国新冠疫情爆发后半封锁期的体重、身体活动及生活方式变化：一项在线调查
Disaster Med Public Health Prep. 2021 Apr;15(2):e23-e28. doi: 10.1017/dmp.2020.237. Epub 2020 Jul 14.
4
Changes in Weight and Nutritional Habits in Adults with Obesity during the "Lockdown" Period Caused by the COVID-19 Virus Emergency.新冠病毒紧急事件期间肥胖成年人的体重和营养习惯变化。
Nutrients. 2020 Jul 7;12(7):2016. doi: 10.3390/nu12072016.
5
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India.新冠疫情期间全国封锁对印度北部2型糖尿病患者生活方式及其他医疗问题的影响
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):917-920. doi: 10.1016/j.dsx.2020.05.044. Epub 2020 Jun 2.
6
Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?阿司匹林是否应用于预防新冠病毒感染所致凝血病？
Med Hypotheses. 2020 Nov;144:109975. doi: 10.1016/j.mehy.2020.109975. Epub 2020 Jun 8.
7
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.高血压和降压治疗与 COVID-19 死亡率的关联：一项回顾性观察研究。
Eur Heart J. 2020 Jun 7;41(22):2058-2066. doi: 10.1093/eurheartj/ehaa433.
8
Obesity and risk of COVID-19: analysis of UK biobank.肥胖与2019冠状病毒病风险：英国生物银行分析
Prim Care Diabetes. 2020 Oct;14(5):566-567. doi: 10.1016/j.pcd.2020.05.011. Epub 2020 May 28.
9
Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.成年人肥胖和重度肥胖的患病率：美国，2017-2018 年。
NCHS Data Brief. 2020 Feb(360):1-8.
10
The association between treatment with heparin and survival in patients with Covid-19.肝素治疗与 COVID-19 患者生存之间的关联。
J Thromb Thrombolysis. 2020 Aug;50(2):298-301. doi: 10.1007/s11239-020-02162-z.
Zotero 插件